Antithrombin for respiratory distress syndrome in preterm infants

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Bassler, Dirk ^a   Millar, D ^b   Schmidt, B ^b  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; PLACEBO; STEROID; SURFACTANT;

ARTIFICIAL VENTILATION; BODY WEIGHT; BRAIN HEMORRHAGE; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DRUG DOSE COMPARISON; DRUG FATALITY; EMBASE; ENDOTRACHEAL INTUBATION; GESTATIONAL AGE; HUMAN; INTUBATION; LIFESPAN; LOADING DRUG DOSE; LUNG DYSPLASIA; LUNG HEMORRHAGE; MEDLINE; NEWBORN MORTALITY; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PNEUMOTHORAX; PREMATURITY; RANDOMIZATION; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT DURATION;

EID: 42749102832     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005383.pub2     Document Type: Review

References (19)

1. Fulia F, Cordaro S, Meo P, Gitto E, Trimarchi G, Adelardi S, Barberi I. Can the administration of antithrombin III decrease the risk of cerebral hemorrhage in premature infants?. Biology of the Neonate 2003;83:1-5.
2. Schmidt B, Gillie P, Mitchell L, Andrew M, Caco C, Roberts R. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 1998;158:470-6.
3. Ambrus JL, Ambrus CM. Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome (ARDS), caused by trauma and/or septic shock in patients and in experimental animals. Journal of Medicine 1990;21:67-84.
4. Brangenberg R, Bodensohn M, Buerger U. Antithrombin-III substitution in preterm infants - effects on intracranial hemorrhage and coagulation parameters. Biology of the Neonate 1997;72:76-83.
5. Muntean W, Rosegger H. Antithrombin III concentrate in preterm infants with IRDS: an open, controlled, randomized clinical trial (abstract). Thrombosis and Haemostasis 1989;62:288.
6. Yurdakok M, Yigit S. Plasma thrombomodulin, plasminogen activator and plasminogen activator inhibitor levels in preterm infants with or without respiratory distress syndrome. Acta Paediatrica 1997;86:1022-3.
7. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefesen DM, Powers P. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72.
8. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Castle V, Powers P. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-7.
9. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. A.M.A. Journal of Diseases of Children 1959;97:517-23.
10. Bick RL. Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and Protein S defects. Hematology/oncology Clinics of North America 2003;17:9-36.
11. Brus F, Van Oeveren W, Okken A, Oetomo SB. Disease severity is correlated with plasma clotting and fibrinolytic and kinin-kallikrein activity in neonatal respiratory distress syndrome. Pediatric Research 1997;41:120-7.
12. Hathaway WE, Neumann LL, Borden CA, Jacobson LJ. Immunologic studies of antithrombin III heparin cofactor in the newborn. Thrombosis and Haemostasis 1978;39:624-30.
13. Malik AB, Horgan MJ. Mechanisms of thrombin-induced lung vascular injury and oedema. American Review of Respiratory Disease 1987;136:467- 70.
14. Peters M, ten Cate JW, Jansen E, Breederveld C. Coagulation and fibrinolytic factors in the first week of life in healthy infants. Journal of Pediatrics 1985;106:292-5.
15. Roemisch J, Gray E, Hoffmann JN, Wiedermann CJ. Antithrombin: a new look at the actions od a serine protease inhibitor. Blood Coagulation & Fibrinolysis 2002;13:657-70.
16. Schmidt B, Vegh P, Weitz J, Johnston M, Caco C, Roberts R. Thrombin/Antithrombin III complex formation in the neonatal respiratory distress syndrome. American Review of Respiratory Disease 1992;145:767-70.
17. Seeger W, Elssner A, Guenther A, Kraemer H, Kalinowski HO. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity. American Journal of Respiratory Cell and Molecular Biology 1993;9:213-20.
18. Soll RF, McQueen MC. Respiratory distress syndrome. In: SinclairJC, BrackenMB editor(s). Effective care of the newborn infant. Oxford: Oxford University Press, 1992:325-358.
19. van den Berg W, Breederveld C, ten Cate JW, Peters M, Borm JJ. Low antithrombin III: accurate predictor of idiopathic respiratory distress syndrome in premature neonates. European Journal of Pediatrics 1989;148:455-8.